Related references
Note: Only part of the references are listed.Use of xanthine oxidase inhibitor febuxostat inhibits renal interstitial inflammation and fibrosis in unilateral ureteral obstructive nephropathy
Hiroki Omori et al.
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2012)
Uric Acid Level and Elevated Blood Pressure in US Adolescents National Health and Nutrition Examination Survey, 1999-2006
Lauren F. Loeffler et al.
HYPERTENSION (2012)
Serum uric acid and chronic kidney disease: the Severance cohort study
Yejin Mok et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2012)
Changes in causes of death and risk of cancer in Danish patients with autosomal dominant polycystic kidney disease and end-stage renal disease
Bjarne Orskov et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2012)
Mechanism-Based Therapeutics for Autosomal Dominant Polycystic Kidney Disease: Recent Progress and Future Prospects
Ming-Yang Chang et al.
NEPHRON CLINICAL PRACTICE (2012)
Inflammation, Oxidative Stress, and Insulin Resistance in Polycystic Kidney Disease
Vandana Menon et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Potentially Modifiable Factors Affecting the Progression of Autosomal Dominant Polycystic Kidney Disease
Vicente E. Torres et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
A Randomized Study of Allopurinol on Endothelial Function and Estimated Glomular Filtration Rate in Asymptomatic Hyperuricemic Subjects with Normal Renal Function
Mehmet Kanbay et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Allopurinol Benefits Left Ventricular Mass and Endothelial Dysfunction in Chronic Kidney Disease
Michelle P. Kao et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Why kidneys fail in autosomal dominant polycystic kidney disease
Jared J. Grantham et al.
NATURE REVIEWS NEPHROLOGY (2011)
Hypertension in Autosomal Dominant Polycystic Kidney Disease
Arlene B. Chapman et al.
ADVANCES IN CHRONIC KIDNEY DISEASE (2010)
Association of Uric Acid With Change in Kidney Function in Healthy Normotensive Individuals
Gianni Bellomo et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2010)
Early Renal Abnormalities in Autosomal Dominant Polycystic Kidney Disease
Esther Meijer et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Effect of Allopurinol in Chronic Kidney Disease Progression and Cardiovascular Risk
Marian Goicoechea et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Sirolimus and Kidney Growth in Autosomal Dominant Polycystic Kidney Disease
Andreas L. Serra et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Everolimus in Patients with Autosomal Dominant Polycystic Kidney Disease
Gerd Walz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Sorafenib inhibits cAMP-dependent ERK activation, cell proliferation, and in vitro cyst growth of human ADPKD cyst epithelial cells
Tamio Yamaguchi et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2010)
Asymmetric dimethylarginine and lipid peroxidation products in early autosomal dominant polycystic kidney disease
Dan Wang et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2008)
Coronary flow velocity reserve and carotid intima media thickness in patients with autosomal dominant polycystic kidney disease: From impaired tubules to impaired carotid and coronary arteries
Kultigin Turkmen et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension - A randomized trial
Daniel I. Feig et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular renin-angiotensin system
Dalila B. Corry et al.
JOURNAL OF HYPERTENSION (2008)
Src inhibition ameliorates polycystic kidney disease
William E. Sweeney et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Uric acid and incident kidney disease in the community
Daniel E. Weiner et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Uric acid and cardiovascular risk
Daniel I. Feig et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Relationship of uric acid with progression of kidney disease
Michel Chonchol et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2007)
Hyperuricemia and incidence of hypertension among men without metabolic syndrome
Eswar Krishnan et al.
HYPERTENSION (2007)
Magnetic resonance measurements of renal blood flow and disease progression in autosomal dominant polycystic kidney disease
Vicente E. Torres et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level
YP Siu et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2006)
Hyperuricemia induces endothelial dysfunction
UM Khosla et al.
KIDNEY INTERNATIONAL (2005)
The intrarenal renin-angiotensin system in autosomal dominant polycystic kidney disease
M Loghman-Adham et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2004)
Endothelial dysfunction and reduced nitric oxide in resistance arteries in autosomal-dominant polycystic kidney disease
D Wang et al.
KIDNEY INTERNATIONAL (2003)
Magnetic resonance measurements of renal blood flow as a marker of disease severity in autosomal-dominant polycystic kidney disease
BF King et al.
KIDNEY INTERNATIONAL (2003)
A role for uric acid in the progression of renal disease
DH Kang et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2002)
Allopurinol improves endothelial dysfunction in chronic heart failure
CA Farquharson et al.
CIRCULATION (2002)
Relationship between renal volume growth and renal function in autosomal dominant polycystic kidney disease: A longitudinal study
GM Fick-Brosnahan et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2002)
Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism
M Mazzali et al.
HYPERTENSION (2001)
Allopurinol normalizes endothelial dysfunction in type 2 diabetics with mild hypertension
R Butler et al.
HYPERTENSION (2000)
Share Paper
